Ligand Pharmaceuticals Inc (LGND) Institutional Ownership

Ownership Summary

Ligand Pharmaceuticals Inc (NASDAQ:LGND) is held by 338 institutional investors per 13F filings through December 2025.

• These investors held 100.1% of outstanding shares in December 2025, down from 178.3% in September 2025.
• They increased total shares held in Ligand Pharmaceuticals by 4.76% from the prior quarter, while the number of investors in LGND increased 33.07% year over year.
• Of these 338 funds, 176 grew their exposure to Ligand Pharmaceuticals, 113 cut back, and 49 maintained positions.
• The aggregate institutional position in Ligand Pharmaceuticals amounted to 20.65Mn shares as of December 2025, up by 939.12K shares quarter on quarter, and up 1.75Mn shares year over year.
• BlackRock, Inc. is the top holder of Ligand Pharmaceuticals as of December 31, 2025, with 2.96Mn shares representing 14.36% of outstanding stock.
• The largest buyers of Ligand Pharmaceuticals for the quarter ending December 2025 were VANGUARD PORTFOLIO MANAGEMENT LLC (1.1Mn), Janus Henderson Group Plc (1.02Mn), VANGUARD CAPITAL MANAGEMENT LLC (848.09K), Invesco Ltd. (307.14K), VANGUARD FIDUCIARY TRUST CO (127.9K).
• Top sellers of LGND stock for the quarter ending December 2025 included Goldman Sachs Group Inc (476.9K), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (150.7K), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (146.3K), JACOBS LEVY EQUITY MANAGEMENT, INC (106.22K), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (95.48K).
• Per Business Quant data, the top 10 holders of Ligand Pharmaceuticals for the quarter ending December 2025 are BlackRock, Inc. (2.96Mn), Janus Henderson Group Plc (2.02Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (1.1Mn), VANGUARD CAPITAL MANAGEMENT LLC (848.09K), Invesco Ltd. (823.6K), State Street Corp (778.86K), FMR LLC (596.13K), NOMURA ASSET MANAGEMENT INTERNATIONAL INC. (573.31K), Franklin Resources Inc (573.18K), Chicago Capital, LLC (561.68K).